Science News
from research organizations

Parasite protein could help inform new anti-tuberculosis strategies

In lab studies, toxoplasmosis parasite proteins stimulate anti-tuberculosis molecular activity

Date:
January 26, 2017
Source:
PLOS
Summary:
Proteins produced by the parasite that causes toxoplasmosis may be involved in immune system processes that can help fight mycobacteria, according to a new study. The findings suggest that these proteins could potentially play a role in new treatment strategies for tuberculosis.
Share:
FULL STORY

Proteins produced by the parasite that causes toxoplasmosis may be involved in immune system processes that can help fight mycobacteria, according to a new study. The findings, published in PLOS Pathogens, suggest that these proteins could potentially play a role in new treatment strategies for tuberculosis.

Tuberculosis infects millions worldwide and kills over two million people each year, mostly in low-and middle-income countries. To improve treatment strategies, scientists have proposed the use of host-directed therapies, which target processes in the human body that help mycobacteria survive and thrive, rather than directly targeting the bacteria themselves.

In the new study, Hyun-Jung Koh and colleagues at Hanyang University in South Korea suggest that proteins produced by a different pathogen, the parasite that causes the disease toxoplasmosis, could play a role in the development of host-directed tuberculosis therapies.

The scientists reported that mycobacteria-infected mice and human cell lines were treated with recombinant GRA7 to investigate the activity of GRA7 proteins, which are produced by the parasites after they infect a host cell. They found that a host protein called PKC? is essential for interactions between GRA7 and host proteins known as ASC and PLD1.

These interactions are known to contribute to anti-tuberculosis defense mechanisms, suggesting the potential for development of GRA7-based host-directed tuberculosis therapies. However, this study was performed in mice and human cells, not in tuberculosis patients, and further research is needed to better understand the molecular role of GRA7 in humans.


Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.


Journal Reference:

  1. Hyun-Jung Koh, Ye-Ram Kim, Jae-Sung Kim, Jin-Seung Yun, Kiseok Jang, Chul-Su Yang. Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCα. PLOS Pathogens, 2017; 13 (1): e1006126 DOI: 10.1371/journal.ppat.1006126

Cite This Page:

PLOS. "Parasite protein could help inform new anti-tuberculosis strategies: In lab studies, toxoplasmosis parasite proteins stimulate anti-tuberculosis molecular activity." ScienceDaily. ScienceDaily, 26 January 2017. <www.sciencedaily.com/releases/2017/01/170126142822.htm>.
PLOS. (2017, January 26). Parasite protein could help inform new anti-tuberculosis strategies: In lab studies, toxoplasmosis parasite proteins stimulate anti-tuberculosis molecular activity. ScienceDaily. Retrieved May 26, 2017 from www.sciencedaily.com/releases/2017/01/170126142822.htm
PLOS. "Parasite protein could help inform new anti-tuberculosis strategies: In lab studies, toxoplasmosis parasite proteins stimulate anti-tuberculosis molecular activity." ScienceDaily. www.sciencedaily.com/releases/2017/01/170126142822.htm (accessed May 26, 2017).

RELATED STORIES